Hermeus Backed by Altman and Thiel Achieves Supersonic Flight Milestone NASA Selects Blue Origin for First Lunar Mission in 20 Billion Moon Base Plan UKGulf Trade Deal Hailed as Monumental Achievement by Bahrain Minister Implications for Bilateral Commerce ChatGPTs Bank Account Access Balancing Innovation with Privacy Risks SpaceX IPO Opens to Retail Investors Through Major Brokerage Platforms Disney Shares Surge 7 as Streaming and Parks Segments Drive Revenue Beat in CEO Josh DAmaros First Earnings Report FCNCN Q1 2026 Earnings Preferred Stock Investors Eye Strong EPS Beat as Bank Outperforms Expectations SBDS Q1 2026 Earnings Significant Loss Reported Amid Operational Challenges Edgewise Therapeutics Q1 2026 Earnings NarrowerthanExpected Loss as Clinical Progress Continues NNN Q1 2026 Earnings Modest EPS Miss as REIT Maintains Disciplined Capital Allocation LSBK Q3 2025 Earnings Steady Profitability Amidst Stable Operations STOK Q1 2026 Earnings Narrowed Loss Beats Estimates as Clinical Pipeline Advances HCM IV Acquisition Corp Unit HACQU Edges Higher Support at 959 Remains Key Mercer International Inc MERC Tests Critical Support After Nearly 5 Decline Parke Bancorp PKBK Edges Higher Support Holds as Stock Approaches Key Resistance SELLAS Life Sciences SLS Rises 291 as Support Holds Above 739 CPS Technologies CPSH Gains 42 as Shares Approach Key 1217 Resistance Level Texas Instruments Upgraded by Seaport Research on Data Center Power Demand Growth GEF Q1 2026 Earnings EPS Beats Estimates Amid Cautious Market Outlook MidCap Financial Investment Notes MFICL Edges Higher 2682 Resistance in Focus Banzai International BNZI Slips 172 as Stock Tests Key Support Near 381 BRC Group Holdings RILY Nears Key Support After Steady Decline Community Trust Bancorp CTBI Slightly Lower as Shares Test Support Levels Jade Biosciences Inc JBIO Faces Headwinds Shares Slide 533 as Key Support Levels Are Tested Taboola Shares Slide as Market Weighs Growth Prospects Community Healthcare Trust CHCT Rallies 104 as Support at 1668 Holds Firm IO Biotech Holds Steady at 005 Navigating Extremely Low Valuation Territory